drug · vaccine component
pneumococcal polysaccharide [21-valent] vaccine
pre_registrationupdated 5mo agoby $MRK Merck & Co., Inc.🔗 ChEMBL
community read0 votes
Vaccine component drug with a maximum clinical stage of Approval (across all indications), with an approval for pneumococcal infection and 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
News(1)
- 10 clinical trials to watch in the second half of 2026The biotechnology sector’s upswing accelerated in the first half. Positive results from anticipated trials in lung cancer, Alzheimer’s and multiple autoimmune conditions could add to the momentum.biopharma_dive · 3mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that